H. Denz

2.4k total citations · 1 hit paper
43 papers, 1.8k citations indexed

About

H. Denz is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, H. Denz has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Oncology and 9 papers in Hematology. Recurrent topics in H. Denz's work include Immune Cell Function and Interaction (10 papers), Advanced Chemical Sensor Technologies (6 papers) and Immunotherapy and Immune Responses (5 papers). H. Denz is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Advanced Chemical Sensor Technologies (6 papers) and Immunotherapy and Immune Responses (5 papers). H. Denz collaborates with scholars based in Austria, Switzerland and Poland. H. Denz's co-authors include Michael Fiegl, Herbert Jamnig, Clemens Ager, Martin Hackl, Wolfgang Hilbe, Dietmar Fuchs, Wojciech Filipiak, Anton Amann, Martin Klieber and Wolfram Miekisch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

H. Denz

43 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive detection of lung cancer by analysis of exhaled breath

2009 480 citations Clemens Ager, Wojciech Filipiak et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Denz Austria	20	997	404	353	329	223	43	1.8k
Guobing Xu China	19	259 0.3×	155 0.4×	134 0.4×	245 0.7×	135 0.6×	83	1.2k
Madhu Sasidhar United States	11	196 0.2×	57 0.1×	103 0.3×	423 1.3×	96 0.4×	30	962
Steven W. Graves United States	28	151 0.2×	186 0.5×	113 0.3×	894 2.7×	74 0.3×	98	2.6k
Adam Antczak Poland	27	300 0.3×	40 0.1×	39 0.1×	554 1.7×	232 1.0×	140	2.9k
A. Meulemans France	25	88 0.1×	55 0.1×	102 0.3×	318 1.0×	133 0.6×	78	2.0k
Lizhen Xu China	20	130 0.1×	209 0.5×	33 0.1×	606 1.8×	36 0.2×	68	1.5k
Norbert Verbeke Belgium	21	199 0.2×	149 0.4×	36 0.1×	405 1.2×	63 0.3×	34	1.5k
Makiko Morita Japan	17	213 0.2×	79 0.2×	17 0.0×	356 1.1×	113 0.5×	46	879
Koichi Yoshida Japan	19	127 0.1×	56 0.1×	59 0.2×	231 0.7×	37 0.2×	99	1.1k
Alfred L. Yergey United States	32	75 0.1×	273 0.7×	27 0.1×	1.0k 3.1×	134 0.6×	81	3.2k

Countries citing papers authored by H. Denz

Since Specialization

Citations

This map shows the geographic impact of H. Denz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Denz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Denz more than expected).

Fields of papers citing papers by H. Denz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Denz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Denz. The network helps show where H. Denz may publish in the future.

Co-authorship network of co-authors of H. Denz

This figure shows the co-authorship network connecting the top 25 collaborators of H. Denz. A scholar is included among the top collaborators of H. Denz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Denz. H. Denz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Filipiak, Wojciech, Veronika Ruzsányi, Paweł Mochalski, et al.. (2012). Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. Journal of Breath Research. 6(3). 36008–36008. 172 indexed citations

Kurz, Katharina, Michael Fiegl, Bernhard Holzner, et al.. (2012). Fatigue in Patients with Lung Cancer Is Related with Accelerated Tryptophan Breakdown. PLoS ONE. 7(5). e36956–e36956. 39 indexed citations

Giesinger, Johannes M., Lisa M. Wintner, Anne Oberguggenberger, et al.. (2011). Quality of Life Trajectory in Patients with Advanced Cancer during the Last Year of Life. Journal of Palliative Medicine. 14(8). 904–912. 65 indexed citations

Murr, Christian, Heribert Talasz, Erika Artner‐Dworzak, et al.. (2007). Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders. Clinical Chemistry and Laboratory Medicine (CCLM). 45(9). 1224–8. 11 indexed citations

Schroecksnadel, Katharina, Barbara Frick, Michael Fiegl, et al.. (2007). Hyperhomocysteinaemia and immune activation in patients with cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 45(1). 47–53. 14 indexed citations

Schroecksnadel, Katharina, et al.. (2007). Diminished quality of life in patients with cancer correlates with tryptophan degradation. Journal of Cancer Research and Clinical Oncology. 133(7). 477–485. 45 indexed citations

Landmann, R., Ulrich Keilholz, Carmen Scheibenbogen, et al.. (1994). Relationship between soluble tumor necrosis factor (TNF) receptors and TNF? during immunotherapy with interleukin-2 and/or interferon ?. Cancer Immunology Immunotherapy. 38(2). 113–118. 10 indexed citations

Obrist, R., H. Denz, Christian Ludwig, et al.. (1993). Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide. Biotherapy. 7(1). 1–12. 15 indexed citations

Denz, H., Günter Weiß, Harald Gallati, et al.. (1993). Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss. European Journal of Cancer. 29(16). 2232–2235. 22 indexed citations

10.

Denz, H., et al.. (1993). Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Journal of Molecular Medicine. 71(1). 37–41. 53 indexed citations

11.

Landmann, R., Christian Ludwig, M. Wesp, et al.. (1992). Prolonged Interferon-γ Application by Subcutaneous Infusion in Cancer Patients: Differential Response of Serum CD14, Neopterin, and Monocyte HLA Class I and II Antigens. Journal of Interferon Research. 12(2). 103–111. 11 indexed citations

12.

Denz, H., Dietmar Fuchs, Arno Hausen, et al.. (1990). Urinary Neopterin in Monoclonal Gammopathies. Pteridines. 2(2). 107–109. 1 indexed citations

13.

Denz, H., Kurt Grünewald, Josef Thaler, et al.. (1989). Urinary Neopterin as a Prognostic Factor in Haematological Neoplasias. Pteridines. 1(3). 167–170. 15 indexed citations

14.

Thaler, Josef, H. Denz, Otto Dietze, et al.. (1989). Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: Changes following treatment with alpha-2-interferon and deoxycoformycin. Leukemia Research. 13(5). 377–383. 14 indexed citations

15.

Nachbaur, David, H. Denz, Günther Gastl, et al.. (1989). Combination effects of human recombinant interferon (alpha-2-arg, gamma) and cytotoxic agents on colony formation of human melanoma and hypernephroma cell lines. Cancer Letters. 44(1). 49–53. 7 indexed citations

16.

Aulitzky, Walter E., Herbert Tilg, Manfred Herold, et al.. (1988). Enhanced Serum Levels of β-2-Microglobulin, Neopterin, and Interferon-γ in Patients Treated with Recombinant Tumor Necrosis Factor-α. Journal of Interferon Research. 8(5). 655–664. 12 indexed citations

17.

Thaler, J., H. Denz, C. Gattringer, et al.. (1987). Diagnostic and prognostic value of immunohistological bone marrow examination: Results in 212 patients with lymphoproliferative disorders. Annals of Hematology. 54(4). 213–222. 24 indexed citations

18.

Denz, H., Monika Lechleitner, Ch. Marth, et al.. (1985). Effect of Human Recombinant Alpha-2-and Gamma-Interferon on the Growth of Human Cell Lines from Solid Tumors and Hematologic Malignancies. Journal of Interferon Research. 5(1). 147–157. 61 indexed citations

19.

Gastl, Günther, H. Denz, Jakob Troppmair, et al.. (1985). Treatment with Low Dose Human Recombinant Interferon-Alpha-2-ARG Induces Complete Remission in Patients with Hairy Cell Leukemia. Oncology Research and Treatment. 8(3). 143–144. 12 indexed citations

20.

Denz, H., Peter Späth, & H. Huber. (1977). Penicillin-induced immunhaemolytic anaemia. Annals of Hematology. 35(3). 171–177. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact